HMGB2 is a potential diagnostic marker and therapeutic target for liver fibrosis and cirrhosis.
Huang Y, Liangpunsakul S, Rudraiah S, Ma J, Keshipeddy SK, Wright D, Costa A, Burgess D, Zhang Y, Huda N, Wang L, Yang Z.
Huang Y, et al.
Hepatol Commun. 2023 Nov 6;7(11):e0299. doi: 10.1097/HC9.0000000000000299. eCollection 2023 Nov 1.
Hepatol Commun. 2023.
PMID: 37930124
Free PMC article.